Characterization of Carboxymaltose Structure and Interactions with the Iron Core in Ferric Carboxymaltose (Injectafer) Using NMR Spectroscopy
Molecular Pharmaceutics · 02.11.2026 · 23 (11) · 5327-5340
DOI: 10.1021/acs.molpharmaceut.6c00375 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 14.10.2026. Verfasst von Tianyun Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Industrial and Molecular Pharmaceutics, Purdue University, 47907-2050West Lafayette, Indiana, United States. Hauptthemen laut MEDLINE: Maltose, Ferric Compounds, Iron. Die Arbeit nennt 30 Literaturangaben. Gefördert von: U.S. Food and Drug Administration.
Abstract (Originalsprache)
Ferric carboxymaltose (FCM), marketed as Injectafer, is an intravenous iron formulation used to treat iron deficiency. It is composed of polynuclear Fe(III)-oxyhydroxide/oxide cores surrounded by carboxymaltose. Although it has been on the market for over 10 years, the structure of carboxymaltose and its interaction with the iron core are not fully understood. This study used nuclear magnetic resonance (NMR) to investigate both the structure of carboxymaltose and how it interacts with the iron core in Injectafer. Carboxymaltose was isolated from Injectafer and compared with other carboxymaltose samples made from maltodextrin with various dextrose equivalents (DEs). The results showed that carboxymaltose from Injectafer resembles most closely a lab-synthesized carboxymaltose with a DE of 4−7. Carboxymaltotriose was also synthesized to help with assigning the peaks in the NMR spectra of carboxymaltose. NMR was also used to study Injectafer in its as-is and diluted form. Compared to the spectra of diluted samples, peaks of the as-is sample were broadened and downfield-shifted in the 13C NMR spectra of Injectafer, due to the presence of iron and possibly due to interactions of carboxymaltose with the iron core. 1H NMR spectra of significantly diluted Injectafer showed 1H NMR peaks adjacent to the carboxy group only at dilutions of 400× or more, whereas the other peaks were observed at 100×. This suggests that the carboxy group interacts with the iron core and that it separates from the core at higher dilutions. Competitive binding studies using both low- and high-molecular-weight carboxymaltose, along with trimethylsilyl propionate (TSP), were used to characterize the binding affinity of carboxy groups to the iron core, as well as the maximum amount of carboxy groups that can bind to the surface of the iron core in Injectafer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Industrial and Molecular Pharmaceutics, Purdue University, 47907-2050West Lafayette, Indiana, United States.
- Office of Pharmaceutical Quality Assessment I, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration, 20993Silver Spring, Maryland, United States.
- Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration, 20993Silver Spring, Maryland, United States.
- Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, 20993Silver Spring, Maryland, United States.
ORCID-Profile: Cole W Tower, Kang Chen, Haiou Qu, Yan Wang, Deyi Zhang, Eric J Munson
Förderung
- U.S. Food and Drug Administration
Zitieren
APA
Zhang, T., Shamim, M. A., Tower, C. W., Sapkota, R., Huls, N. J., Liu, D., Chen, K., Qu, H., Jiang, W., Wang, Y., Zhang, D., & Munson, E. J. (2026). Characterization of Carboxymaltose Structure and Interactions with the Iron Core in Ferric Carboxymaltose (Injectafer) Using NMR Spectroscopy. Molecular Pharmaceutics, 23(11), 5327-5340. https://doi.org/10.1021/acs.molpharmaceut.6c00375
Vancouver
Zhang T, Shamim MA, Tower CW, Sapkota R, Huls NJ, Liu D, et al. Characterization of Carboxymaltose Structure and Interactions with the Iron Core in Ferric Carboxymaltose (Injectafer) Using NMR Spectroscopy. Molecular Pharmaceutics. 2026;23(11):5327-5340. doi:10.1021/acs.molpharmaceut.6c00375
BibTeX
@article{Zhang2026,
author = {Zhang, Tianyun and Shamim, Md Abdullah and Tower, Cole W and Sapkota, Rachana and Huls, Nicholas J and Liu, Dahui and Chen, Kang and Qu, Haiou and Jiang, Wenlei and Wang, Yan and Zhang, Deyi and Munson, Eric J},
title = {Characterization of Carboxymaltose Structure and Interactions with the Iron Core in Ferric Carboxymaltose (Injectafer) Using NMR Spectroscopy},
journal = {Molecular Pharmaceutics},
year = {2026},
volume = {23},
number = {11},
pages = {5327--5340},
doi = {10.1021/acs.molpharmaceut.6c00375}
}
EUVIMED